miR-29a reversed FoxO3 loss to improve senescence program through targeting Dnmt3b-mediated FoxO3 methylation and increased antioxidant proteins, including Oxr1, to downregulate oxidative stress and DNA methylation, compromising age-induced osteoblast loss and osteoporosis (Figure 8f). This evidence concerns the gene FOXO3 and osteoporosis.